Description

AtriCure, Inc., a medical device company, provides atrial fibrillation solutions to hospitals and medical centers in the United States and internationally. The company offers Isolator Synergy System and related radio frequency(RF) ablation devices, which include clamps that are used for ablation during open-heart procedures; ablation and sensing unit, a compact power generator that delivers bipolar RF energy to its clamps, multifunctional pens, and Coolrail linear ablation devices; AtriCure Switch Box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in clamps; and Coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. It also provides Isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias; perform temporary cardiac pacing, sensing, and stimulation; and ablate cardiac tissue with the same device. In addition, the company provides COBRA Fusion Surgical Ablation System and EPi-Sense Guided Coagulation System; electrosurgical unit, a compact power generator for use with Fusion ablation products; AFfirm Bipolar Pacing Probe is used to test lesions created in surgically treating the patient’s arrhythmia; cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; AtriClip system that is designed for the left atrial appendage management; nContact RF generator; and Cannula, an access device and conduit for the ablation device. Further, it sells Lumitip dissector to separate tissues to provide access to anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments that are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products through independent distributors and direct sales personnel. AtriCure, Inc. is headquartered in Mason, Ohio.